NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ilya Pharma

Ilya Pharma

Private
UppsalaHealthcare & Life Scienceshttps://www.ilyapharma.se/

Last Round

VC Round

Aug 14, 2024

Total Funding Raised

$14.15M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ilya Pharma is a clinical-stage biotechnology company that develops novel biological drugs using lactic acid bacteria as vectors to treat wounds in skin and mucosa.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalimmunotherapyadvanced therapy medicinal productsATMPgenetically modified bacteriawound healingbioanalytical servicesdrug developmentbiotechgastrointestinal disease treatmenttherapeutic proteinsclinical trialslive biotherapeutic productsLBPdrug delivery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ilya Pharma Comparables

Compare Ilya Pharma with similar companies based on industry and business-model similarity.

Ilya Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aurealis Therapeutics
92%
SolasCure
81%
ResVita Bio
80%

Ilya Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 14, 2024
VC RoundMar 17, 2022
GrantJul 9, 2020
AcceleratorJun 8, 2020
Series ASep 10, 2018
Grant
Nov 30, 2017

Key People

Founding team and executive leadership

Evelina Vågesjö

CEO

Executive Team

Ilya Pharma Investors

Notable investors and investment history

Ilya Pharma investors
InvestorRounds
European Innovation Council FundAccelerator
European CommissionGrant
EIT HealthGrant
VinnovaGrant
EIC FundVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 67% MoM, reaching 2.9K.

  • Jul 10, 2017

    $510K raised in Pre Seed round.

Ilya Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ilya Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ilya Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersUppsala
Employee Range13
Year Founded2016
Last FundingAug 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.